PAVmed Inc (PAVMZ)
NASDAQ: PAVMZ
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 30, 2025, 1:52 PM
PAVmed Inc Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3M | 4.03M | 3.83M | 3.02M | 2.45M | 1.51M | 800K | 634K | 377K | 565K | 689K | 689K | 500K | 200K | n/a | n/a |
Cost of Revenue | 5.73M | 8.02M | 8.42M | 8.13M | 7.15M | 6.43M | 6.28M | 5.41M | 4.43M | 3.25M | 1.77M | 970K | 613K | 172K | 28K | 12K |
Gross Profit | -2.73M | -3.98M | -4.59M | -5.11M | -4.69M | -4.91M | -5.47M | -4.77M | -4.05M | -2.69M | -1.08M | -281K | -113K | 28K | -28K | -12K |
Operating Income | -44.48M | -55.68M | -59.63M | -62.43M | -68.8M | -76.92M | -84.7M | -91.69M | -90.75M | -85.93M | -76.28M | -65.78M | -54.39M | -42.27M | -34.13M | -26.18M |
Interest Income | 254K | 349K | 403K | 456K | 505K | 631K | 1.03M | 876K | 757K | 534K | 9K | 2K | n/a | n/a | n/a | n/a |
Pretax Income | 28.43M | 9.88M | -72.58M | -75.56M | -79.26M | -86.43M | -94.61M | -105.82M | -103.24M | -98.34M | -82.08M | -65.65M | -56.13M | -45.71M | -37.91M | -31.09M |
Net Income | 39.79M | 24.32M | -57.82M | -61.53M | 4.14B | 4.13B | 4.13B | 4.11B | -89.05M | -85.74M | -71.84M | -57.79M | -50.35M | -41.87M | -35.13M | -29.23M |
Selling & General & Admin | 35.94M | 43.1M | 44.4M | 44.14M | 47.92M | 52.24M | 56.42M | 62.17M | 60.96M | 63.5M | 54.43M | 44.44M | 35.85M | 21.4M | 18.32M | 14.47M |
Research & Development | 5.93M | 8.72M | 10.34M | 12.17M | 14.66M | 17.74M | 20.78M | 24.05M | 25.55M | 25.84M | 24.95M | 22.46M | 19.85M | 16.52M | 13.83M | 11.71M |
Other Expenses | 371.88M | 377.65M | 378.08M | 377.94M | 6.44M | 1.18M | 1.18M | -3.58M | -4.26M | -10.86M | -8.93M | -1.85M | n/a | 11.61M | 9.54M | 9.69M |
Operating Expenses | 41.75M | 51.7M | 55.04M | 57.32M | 64.1M | 72M | 79.23M | 87.74M | 87.52M | 84.06M | 76.02M | 65.51M | 54.31M | 42.33M | 34.13M | 26.18M |
Interest Expense | 46K | 58K | 205K | 422K | 589K | 793K | 1.16M | 1.45M | 4.03M | 6.27M | 5.75M | 5.22M | 2.46M | n/a | n/a | n/a |
Selling & Marketing Expenses | 11.63M | 16.16M | 17.26M | 16.9M | 17.13M | 18.2M | 18.92M | 19.93M | 19.32M | 22.45M | 20.01M | 16.99M | 14.45M | 6.81M | 5.21M | 3.79M |
Cost & Expenses | 47.48M | 59.72M | 63.46M | 65.45M | 71.25M | 78.43M | 85.5M | 92.33M | 91.13M | 86.49M | 76.97M | 66.47M | 54.89M | 42.47M | 34.13M | 26.18M |
Income Tax Expense | 4.28B | 4.27B | 4.27B | 988.63M | -7.5B | -7.5B | -7.5B | -4.22B | -14.19M | -12.6M | -10.24M | -7.86M | -5.78M | -3.84M | -2.79M | -1.85M |
Shares Outstanding (Basic) | 11.2M | 10.01M | 9.15M | 8.69M | 8.22M | 7.46M | 6.96M | 6.47M | 6.3M | 5.98M | 5.8M | 5.76M | 5.76M | 5.55M | 5.48M | 4.93M |
Shares Outstanding (Diluted) | 11.2M | 10.01M | 9.15M | 8.69M | 8.22M | 7.46M | 6.96M | 6.47M | 6.3M | 5.98M | 5.8M | 5.76M | 5.76M | 5.55M | 5.48M | 4.93M |
EPS (Basic) | 2.76 | 0.68 | -8.13 | -9.04 | -9.2 | -10.52 | -12.52 | -14.83 | -14.99 | -14.74 | -12.57 | -10.26 | -9.25 | -8.81 | -8.32 | -8.1 |
EPS (Diluted) | 2.76 | 0.68 | -8.13 | -9.04 | -9.2 | -10.52 | -12.52 | -14.83 | -14.99 | -14.74 | -12.57 | -10.26 | -9.25 | -8.81 | -8.32 | -8.1 |
EBITDA | 29.67M | 11.79M | -70.03M | -72.24M | -75.55M | -82.5M | -90.32M | -101.28M | -99.47M | -95.38M | -80.33M | -65.22M | -53.87M | -43.61M | -35.84M | -29.02M |
EBIT | 28.47M | 9.94M | -72.38M | -75.14M | -78.67M | -85.64M | -93.45M | -104.36M | -101.97M | -97.3M | -81.56M | -65.65M | -54.09M | -43.67M | -35.88M | -29.05M |
Depreciation & Amortization | 1.2M | 1.85M | 2.35M | 2.9M | 3.12M | 3.14M | 3.13M | 3.09M | 2.5M | 1.92M | 1.24M | 442K | 238K | 78K | 42K | 32K |